Abstract |
Endothelin-1 (ET-1) is well known as the most potent vasoconstrictor, and can evoke histamine-independent pruritus. Recently, its involvement in cutaneous inflammation has begun to draw attention. The upregulation of ET-1 expression in the epidermis of human psoriasis patients has been reported. It was also demonstrated that ET-1 can stimulate dendritic cells to induce Th17/1 immune responses. However, the role of the interaction between ET-1 and ET-1 receptors in the pathogenesis of psoriasis remains elusive. Here, we investigated the effects of ET-1 receptor antagonist on imiquimod (IMQ) -induced psoriasiform dermatitis in mouse. Psoriasis-related cytokines such as IL-17A and TNF-α induced ET-1 expression in human keratinocytes. Topical application of selective endothelin A receptor (ETAR) antagonist ambrisentan significantly attenuated the development of IMQ-induced psoriasiform dermatitis and also significantly inhibited the histological inflammation and cytokine expression (TNF-α, IL-12p40, IL-12 p19, and IL-17) in the lesional skin of the mouse model. Furthermore, topical application of ambrisentan suppressed phenotypic and functional activation of dendritic cells in lymph nodes. Our findings indicate that the ET-1 and ETAR axis plays an important role in the pathogenesis of psoriasis and is a potential therapeutic target for treating psoriasis.
|
Authors | Takeshi Nakahara, Makiko Kido-Nakahara, Dugarmaa Ulzii, Sho Miake, Kei Fujishima, Sawako Sakai, Takahito Chiba, Gaku Tsuji, Masutaka Furue |
Journal | Scientific reports
(Sci Rep)
Vol. 10
Issue 1
Pg. 9510
(06 11 2020)
ISSN: 2045-2322 [Electronic] England |
PMID | 32528072
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cytokines
- Endothelin Receptor Antagonists
- Endothelin-1
- Phenylpropionates
- Pyridazines
- Receptors, Endothelin
- ambrisentan
- Imiquimod
|
Topics |
- Administration, Topical
- Animals
- Cytokines
(metabolism)
- Endothelin Receptor Antagonists
(administration & dosage, pharmacology, therapeutic use)
- Endothelin-1
(metabolism)
- Gene Expression Regulation
(drug effects)
- Humans
- Imiquimod
(adverse effects)
- Mice
- Phenylpropionates
(administration & dosage, pharmacology, therapeutic use)
- Psoriasis
(chemically induced, drug therapy, metabolism, prevention & control)
- Pyridazines
(administration & dosage, pharmacology, therapeutic use)
- Receptors, Endothelin
(metabolism)
- Skin
(drug effects, pathology)
|